PNT insider transactions
POINT Biopharma Global Inc. (PNT) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
Recent Form 3, 4, and 5 filings for PNT
- SEC Form 4 filed by Goodman Jonathan R.4 - POINT Biopharma Global Inc. (0001811764) (Issuer)
- SEC Form 4 filed by Kelly Justyna4 - POINT Biopharma Global Inc. (0001811764) (Issuer)
- Mccann Joe A. closing all direct ownership in the company (SEC Form 4)4 - POINT Biopharma Global Inc. (0001811764) (Issuer)
- SEC Form 4 filed by Jensen Jessica D.4 - POINT Biopharma Global Inc. (0001811764) (Issuer)
- Fleshner Neil E. closing all direct ownership in the company (SEC Form 4)4 - POINT Biopharma Global Inc. (0001811764) (Issuer)
- Hogue Gerald L. closing all direct ownership in the company (SEC Form 4)4 - POINT Biopharma Global Inc. (0001811764) (Issuer)
- Malik Rajesh closing all direct ownership in the company (SEC Form 4)4 - POINT Biopharma Global Inc. (0001811764) (Issuer)
- Lubner David Charles returned 3,600 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - POINT Biopharma Global Inc. (0001811764) (Issuer)
- SEC Form 4 filed by Demers William L.4 - POINT Biopharma Global Inc. (0001811764) (Issuer)
- SEC Form 4 filed by Silber Allan C4 - POINT Biopharma Global Inc. (0001811764) (Issuer)
- Margolin Yael returned 1,710 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - POINT Biopharma Global Inc. (0001811764) (Issuer)
- Bvf Partners L P/Il sold $213,657,911 worth of shares (17,161,278 units at $12.45) (SEC Form 4)4 - POINT Biopharma Global Inc. (0001811764) (Issuer)
- Mccann Joe A. gifted 120,000 shares (SEC Form 4)4 - POINT Biopharma Global Inc. (0001811764) (Issuer)
- Silber Allan C gifted 500,000 shares (SEC Form 4)4 - POINT Biopharma Global Inc. (0001811764) (Issuer)
- New insider Bvf Partners L P/Il claimed ownership of 17,161,278 shares (SEC Form 3)3 - POINT Biopharma Global Inc. (0001811764) (Issuer)
- Fleshner Neil E. gifted 250,000 shares, decreasing direct ownership by 8% to 2,773,045 units (SEC Form 4)4 - POINT Biopharma Global Inc. (0001811764) (Issuer)
- SEC Form 4 filed by Martell Bridget A4 - POINT Biopharma Global Inc. (0001811764) (Issuer)
- SEC Form 3 filed by new insider Martell Bridget A3 - POINT Biopharma Global Inc. (0001811764) (Issuer)
- SEC Form 4 filed by Hogue Gerald L.4 - POINT Biopharma Global Inc. (0001811764) (Issuer)
- SEC Form 4 filed by Goodman Jonathan R.4 - POINT Biopharma Global Inc. (0001811764) (Issuer)
- SEC Form 4 filed by Malik Rajesh4 - POINT Biopharma Global Inc. (0001811764) (Issuer)
- SEC Form 4 filed by Margolin Yael4 - POINT Biopharma Global Inc. (0001811764) (Issuer)
- SEC Form 4 filed by Lubner David Charles4 - POINT Biopharma Global Inc. (0001811764) (Issuer)
- SEC Form 4 filed by Silber Allan C4 - POINT Biopharma Global Inc. (0001811764) (Issuer)
- SEC Form 4 filed by Mccann Joe A.4 - POINT Biopharma Global Inc. (0001811764) (Issuer)
- SEC Form 4 filed by Kelly Justyna4 - POINT Biopharma Global Inc. (0001811764) (Issuer)
- SEC Form 4 filed by Jensen Jessica D.4 - POINT Biopharma Global Inc. (0001811764) (Issuer)
- SEC Form 4 filed by Fleshner Neil E.4 - POINT Biopharma Global Inc. (0001811764) (Issuer)
- SEC Form 4 filed by Demers William L.4 - POINT Biopharma Global Inc. (0001811764) (Issuer)
- SEC Form 4 filed by Hogue Gerald L.4 - POINT Biopharma Global Inc. (0001811764) (Issuer)
- SEC Form 4: Mccann Joe A. bought $14,342 worth of shares (2,160 units at $6.64), increasing direct ownership by 0.06% to 3,616,313 units4 - POINT Biopharma Global Inc. (0001811764) (Issuer)
- SEC Form 4: Hogue Gerald L. bought $24,943 worth of shares (3,660 units at $6.82)4 - POINT Biopharma Global Inc. (0001811764) (Issuer)
- SEC Form 4: Lubner David Charles bought $24,660 worth of shares (3,600 units at $6.85)4 - POINT Biopharma Global Inc. (0001811764) (Issuer)
- SEC Form 4: Malik Rajesh bought $24,642 worth of shares (3,700 units at $6.66)4 - POINT Biopharma Global Inc. (0001811764) (Issuer)
- SEC Form 4: Margolin Yael bought $11,218 worth of shares (1,710 units at $6.56)4 - POINT Biopharma Global Inc. (0001811764) (Issuer)
- SEC Form 4: Goodman Jonathan R. bought $37,980 worth of shares (6,000 units at $6.33)4 - POINT Biopharma Global Inc. (0001811764) (Issuer)
- SEC Form 4: Silber Allan C bought $311,198 worth of shares (50,000 units at $6.22), increasing direct ownership by 1% to 4,268,605 units4 - POINT Biopharma Global Inc. (0001811764) (Issuer)
- SEC Form 4 filed by Goodman Jonathan R.4 - POINT Biopharma Global Inc. (0001811764) (Issuer)
- SEC Form 4 filed by Hogue Gerald L.4 - POINT Biopharma Global Inc. (0001811764) (Issuer)
- SEC Form 4 filed by Lubner David Charles4 - POINT Biopharma Global Inc. (0001811764) (Issuer)
- SEC Form 4 filed by Margolin Yael4 - POINT Biopharma Global Inc. (0001811764) (Issuer)
- SEC Form 4 filed by Malik Rajesh4 - POINT Biopharma Global Inc. (0001811764) (Issuer)
- SEC Form 4: Fleshner Neil E. sold $4,237,172 worth of shares (564,204 units at $7.51), decreasing direct ownership by 16% to 3,023,045 units4 - POINT Biopharma Global Inc. (0001811764) (Issuer)
- SEC Form 4 filed by Jensen Jessica D.4 - POINT Biopharma Global Inc. (0001811764) (Issuer)
- SEC Form 4 filed by Silber Allan C4 - POINT Biopharma Global Inc. (0001811764) (Issuer)
- SEC Form 4 filed by Jensen Jessica D.4 - POINT Biopharma Global Inc. (0001811764) (Issuer)
- SEC Form 4 filed by Kelly Justyna4 - POINT Biopharma Global Inc. (0001811764) (Issuer)
- SEC Form 4 filed by Demers William L.4 - POINT Biopharma Global Inc. (0001811764) (Issuer)
- SEC Form 4 filed by Mccann Joe A.4 - POINT Biopharma Global Inc. (0001811764) (Issuer)
- SEC Form 4 filed by Fleshner Neil E.4 - POINT Biopharma Global Inc. (0001811764) (Issuer)
- SEC Form 5 filed by Silber Allan C (Amendment)5/A - POINT Biopharma Global Inc. (0001811764) (Issuer)
- SEC Form 5 filed by Silber Allan C5 - POINT Biopharma Global Inc. (0001811764) (Issuer)
- SEC Form 4: Goodman Jonathan R. was granted 35,872 shares (Amendment)4/A - POINT Biopharma Global Inc. (0001811764) (Issuer)
- SEC Form 4 filed by Kelly Justyna4 - POINT Biopharma Global Inc. (0001811764) (Issuer)
- SEC Form 3 filed by new insider Kelly Justyna3 - POINT Biopharma Global Inc. (0001811764) (Issuer)